sunitinib stada 12,5 mg kapsułki twarde
stada arzneimittel ag - sunitinibum - kapsułki twarde - 12,5 mg
sunitinib stada 25 mg kapsułki twarde
stada arzneimittel ag - sunitinibum - kapsułki twarde - 25 mg
sunitinib stada 37,5 mg kapsułki twarde
stada arzneimittel ag - sunitinibum - kapsułki twarde - 37,5 mg
sunitinib stada 50 mg kapsułki twarde
stada arzneimittel ag - sunitinibum - kapsułki twarde - 50 mg
tagrisso
astrazeneca ab - osimertinib mesilate - rak, niedrobnokomórkowe płuca - inne leki przeciwnowotworowe, inhibitory białka kinazy - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.
ranimax teva 150 mg tabletki powlekane
teva pharmaceuticals polska sp. z o.o. - ranitidini hydrochloridum - tabletki powlekane - 150 mg
ranigast 0,5 mg/ml roztwór do infuzji
zakłady farmaceutyczne polpharma s.a. - ranitidinum - roztwór do infuzji - 0,5 mg/ml
ranigast 150 mg tabletki powlekane
zakłady farmaceutyczne polpharma s.a. - ranitidini hydrochloridum - tabletki powlekane - 150 mg
ranisan 150 mg 150 mg tabletki powlekane
pro.med.cs praha a.s. - ranitidini hydrochloridum - tabletki powlekane - 150 mg
zantac 150 mg tabletki powlekane
glaxosmithkline (ireland) limited - ranitidini hydrochloridum - tabletki powlekane - 150 mg